MY Logo: M for Molecular, Y just like Antibody and ending letter of Biotechnology, Orange Circle inside Y is Antigen or ENzyme, 4 short yellow end signifies pIII coat protein that is decorating.the rounded tip of filamentous phage particle

Celebrating the Latest Publication on Phage Display and Cancer Immunotherapy!

A massive congratulations to the brilliant minds behind the new review article in New BIOTECHNOLOGY: Polina V. Istomina, Andrey A. Gorchakov, Chatchanok Paoin, and Montarop Yamabhai! Your work, “Phage display for discovery of anticancer antibodies,” is a compelling testament. It demonstrates the power of this technology in the fight against cancer.

What truly excites me about this review is its elegant breakdown. It shows how phage display is being used to craft exquisitely precise weapons against cancer. It’s not just about finding any antibody; it’s about engineering the best antibody for the job. The authors expertly guide us through the nuances of antibody formats. They explain the art of guided selection. They also detail the intricacies of humanization and affinity maturation. The authors discuss the crucial considerations for antibody developability.

This review is a must-read for anyone passionate about:
• The future of cancer treatment: Phage display is unlocking a new era of targeted therapies. This review provides a front-row seat to the action.
• Cutting-edge antibody engineering: The authors provide a masterclass. They explain how phage display is being used to craft the next generation of anticancer antibodies.
• The intricate world of antibody discovery: From library construction to selection strategies. This review demystifies the process of finding those rare antibodies with therapeutic potential.

Congratulations again to the authors for sharing their expertise with the scientific community! Your work is an inspiration, and I eagerly anticipate the groundbreaking discoveries it will undoubtedly inspire.
This comprehensive review delves into the groundbreaking world of phage display technology. It also explores its pivotal role in the fight against cancer. The authors provide a concise yet thorough overview of the principles underpinning phage display. This makes it accessible to both seasoned researchers and those new to this powerful technique.

Unraveling the Potential of Phage Display
The review meticulously examines various approaches to library construction and selection strategies. It offers a practical guide for researchers seeking to harness the full potential of phage display for antibody discovery. Furthermore, it sheds light on the critical aspects of antibody engineering through phage display. These aspects include antibody formats, guided selection, humanization, affinity maturation, and antibody developability.
The authors conclude by providing a compelling overview of the current landscape of anticancer antibodies derived from phage display technology. They highlight the tangible impact of this technology on cancer immunotherapy.

Article Highlights:
• Concise review of principles of phage display technology.
• Various approaches for library construction and selection strategies.
• Antibody engineering via phage display technology.
• Ab formats, guided selection, humanization, affinity maturation, Ab developability.
• Current landscape of anticancer antibodies derived from phage display technology.

A Must-Read for Researchers in Cancer Immunotherapy
This publication stands as a testament to the authors’ expertise and dedication to advancing the field of cancer immunotherapy. We highly recommend this article to researchers, clinicians, and anyone passionate about the development of novel cancer treatments. Congratulations again to the authors on this significant contribution!

Harnessing the Power of Antibodies: A Groundbreaking Advancement in Skin Microbiome Research

Congratulations to the Esteemed Researchers on their Groundbreaking Publication!
In the ever-evolving landscape of biotechnology and medical research, the scientific community is abuzz with excitement over the remarkable achievements of a talented team of researchers. Their latest publication, “Anti-CAMP1 IgG promotes macrophage phagocytosis of Cutibacterium acnes type II,” has sparked a wave of enthusiasm and acclaim throughout the field.
Leading this trailblazing effort are the esteemed researchers:
First Author: Thae Thae Min, Molecular Biotechnology Laboratory, School of Biotechnology, Institute of Agricultural Technology, Suranaree University of Technology, Nakhon Ratchasima 30000, Thailand
Co-authors: Kiattawee Choowongkomon, Department of Biochemistry, Faculty of Science, Kasetsart University, Bangkok 10900, Thailand; Htut Htut Htoo, Institute of Molecular Biosciences, Mahidol University, Salaya, Nakhon Pathom 73170, Thailand; Poochit Nonejuie, Molecular Biotechnology Laboratory, School of Biotechnology, Institute of Agricultural Technology, Suranaree University of Technology, Nakhon Ratchasima 30000, Thailand; Dietmar Haltrich, Department of Food Sciences and Technology, University of Natural Resources and Life Sciences, Vienna 1190, Austria
Corresponding Author: Montarop Yamabhai, Molecular Biotechnology Laboratory, School of Biotechnology, Institute of Agricultural Technology, Suranaree University of Technology, Nakhon Ratchasima 30000, Thailand
This groundbreaking study, published in the prestigious journal Phytomedicine, delves deep into the intricate relationship between the immune system and the skin microbiome, with a particular focus on the role of Anti-CAMP1 IgG in enhancing macrophage phagocytosis of Cutibacterium acnes type II.
“We are thrilled to share this remarkable discovery with the scientific community,” exclaimed Professor Montarop Yamabhai, the Corresponding Author. “This research has the potential to pave the way for innovative treatments and revolutionize our understanding of the complex interplay between the immune system and skin microbiome.”
The research team’s dedication and scientific rigor have been instrumental in unraveling the mechanisms behind this groundbreaking finding. Their work has uncovered key highlights, including:
  • The identification of the target of yPac1A8 scFv as the Christie-Atkins-Munch-Petersen factor (CAMP)1 of C. acnes type II.
  • Insightful 3D modeling that reveals how the complementarity-determining regions (CDRs) of the scFv bind to the N-terminal α-helix of CAMP1.
  • The demonstration that yPac1A8 scFv and IgG bind specifically to CAMP1 of phylotype II.
  • The discovery that recombinant IgG enhances human macrophage phagocytosis via the induction of IL-1β.
The collaborative efforts of this esteemed team, spanning diverse areas of expertise and renowned institutions, have culminated in a remarkable achievement that will undoubtedly inspire and propel the field of biotechnology and medical research forward.
We extend our heartfelt congratulations to Thae Thae Min, Kiattawee Choowongkomon, Htut Htut Htoo, Poochit Nonejuie, Dietmar Haltrich, and Montarop Yamabhai on this prestigious publication. Your dedication, innovation, and unwavering commitment to advancing scientific knowledge are truly commendable. We eagerly anticipate the future breakthroughs that will undoubtedly stem from your groundbreaking work.
Prepare to be amazed, as the future of dermatology and immune system research is about to be transformed, thanks to the remarkable efforts of this extraordinary research team.